Join to view full profile
10 E 102nd StNew York, NY 10029
Phone+1 212-241-6756
Dr. Azzi is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalResidency, Internal Medicine, 2017
University of Balamand Faculty of MedicineClass of 2012
Certifications & Licensure
NY State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant Start of enrollment: 2023 Dec 11
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.Sanjal H Desai, Susan M Geyer, Levi Pederson, Michael A Spinner, Veronika Bachanova
Blood Cancer Journal. 2026-06-25 - Impact of Complete Response on Long-Term Survival in Patients with Relapsed or Refractory Large B-cell Lymphoma: A Center for International Blood and Marrow Transplant...Armin Ghobadi, Theodora Anagnostou, Jacques Azzi, Mehdi Hamadani, Brent Logan
Transplantation and Cellular Therapy. 2026-05-01 - 2 citationsA phase 1/2 study of donor-derived anti-CD33 CAR T-cell therapy (VCAR33) for relapsed/refractory AML after allogeneic HCT.Muhammad Umair Mushtaq, John F DiPersio, Jacques Azzi, Brenda W Cooper, Guenther Koehne
Blood. 2026-04-23
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










